$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > Ribociclib

乳腺癌|乳腺癌特药

CDK4/6靶向药治疗激素受体阳性人表皮生长因子受体2(HER-2)阴性晚

瑞波西利|上市信息

新药获美国FDA批! 瑞波西利(Ribociclib)结合芳香酶抑制剂或成为HR

瑞波西利|最新研究

CDK4/6抑制剂Ribociclib各亚组全面获益,多维度彰显实力